Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MS, RN

Abstract

* Hydroxyprogesterone caproate (Makena) is the first drug approved to prevent preterm labor.

 

* Hydroxyprogesterone caproate is given weekly by injection to women who've had at least one premature birth.

 

* It's intended for use only in singleton pregnancies.

 

* Injection-site reactions are the most common adverse effect; others are hives, nausea, and diarrhea.